semaglutide breast cancer GLP-1 Medications and Cancer: What the Latest Research Shows GLP-1 medications may improve survival
Description
Long-term clinical trials demonstrated modest but statistically significant reductions in HbA1c of 0.3-0.68% when pramlintide was added to optimized insulin therapy, confirming sustained improvement in overall glycemic control
They are not designed to be a quick fix
Since the GLP-1 hormone acts directly on the stomach muscles by reducing the rate of gastric contractions, Wegovys amplified dose has caused individuals to experience a pronounced slowing of gastric emptying, which has caused severe gastroparesis side effects
That adds up over months and years, making weight regain more likely
Our team will work with you to develop a sustainable plan that includes building healthy lifestyle habits alongside your medication treatment
